Opportunity Information: Apply for RFA DA 09 016
Apply for RFA DA 09 016
- The National Institutes of Health in the education health sector is offering a public funding opportunity titled "Behavioral Pharmacology and Genetics Translating and Targeting Individual Differences (R03)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.279 Drug Abuse and Addiction Research Programs.
- This funding opportunity was created on Oct 1, 2008 and posted on Oct 1, 2008.
- Applicants must submit their applications by Jan 27, 2009. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The funding agency has allocated a total of $2,000,000.00 to eligible and selected applicants.
- Eligible applicants include: Native American tribal governments (Federally recognized) Private institutions of higher education County governments Special district governments Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Public housing authorities/Indian housing authorities Independent school districts State governments Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education For profit organizations other than small businesses Public and State controlled institutions of higher education Native American tribal organizations (other than Federally recognized tribal governments) Small businesses City or township governments Others (see text field entitled Additional Information on Eligibility for clarification).
- Other Eligible Applicants include the following Alaska Native and Native Hawaiian Serving Institutions Eligible Agencies of the Federal Government Faith based or Community based Organizations Hispanic serving Institutions Historically Black Colleges and Universities (HBCUs) Indian/Native American Tribal Governments (Other than Federally Recognized) Non domestic (non U.S.) Entities (Foreign Organizations) Regional Organizations Tribally Controlled Colleges and Universities (TCCUs) U.S. Territory or Possession.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The Behavioral Pharmacology and Genetics Translating and Targeting Individual Differences (R03) funding opportunity (RFA-DA-09-016) is a National Institutes of Health grant program focused on why people differ in how they respond to drugs of abuse and how those differences may shape risk for drug misuse and addiction. The central idea is that variability in drug effects is not random; it can reflect underlying genetic differences that influence vulnerability or resilience. The opportunity is aimed at studies that connect measurable drug-related behaviors observed under controlled conditions with genetic factors that may help explain those behaviors.
The scientific purpose is to support research that uses controlled, human laboratory-based experimental methods to measure behavior (for example, acute drug response, reinforcement, craving, subjective effects, cognitive or psychomotor changes, stress reactivity, or other quantifiable behavioral outcomes) and pairs those measures with genetic analyses. Projects are expected to examine drug abuse phenotypes (observable characteristics related to drug use and misuse) and/or endophenotypes (more specific, measurable traits that sit between genes and broad clinical outcomes). The announcement highlights three main target areas: (a) genetic contributions to individual differences in response to drugs of abuse, (b) genetic influences on how people differ in the consequences of repeated drug use or abuse over time, and (c) pharmacogenetic differences in how individuals respond to medications that are being tested or already used to treat addiction. The underlying goal is to identify genetic variations that clarify the biochemical and biological mechanisms of drug effects and the behavioral processes tied to addiction risk, and to use that knowledge to point toward more personalized, genetically informed treatment approaches.
This opportunity uses the NIH R03 mechanism, which is designed for small, short-term projects that can be completed with limited resources. In practical terms, it is meant to fund pilot studies, feasibility studies, and other compact, self-contained projects that generate early data or test a new approach. A major emphasis is also placed on encouraging new collaborations, particularly partnerships that bring together expertise in genetics with expertise in drug abuse research and human behavioral pharmacology. The program is positioned as a stepping stone: teams can use R03 support to develop preliminary findings and methods that would make them more competitive for a larger, longer-term R01 application later.
From an administrative standpoint, the opportunity is categorized as a discretionary grant in the health and education-related research area, with the relevant CFDA number listed as 93.279 (Drug Abuse and Addiction Research Programs). The program does not require cost sharing or matching. The estimated total funding amount is $2,000,000 for the competition cycle referenced in the notice. The funding announcement was posted on October 1, 2008, with an original and current closing date of January 27, 2009, and an archive date of February 27, 2009.
Eligibility is broad and includes many types of U.S. and non-U.S. organizations. Eligible applicants include public and private institutions of higher education, nonprofit organizations (including those with and without 501(c)(3) status), for-profit organizations (other than small businesses and including small businesses where applicable), and a range of government entities such as state, county, city/township, special district governments, and independent school districts. The eligibility list also explicitly includes Native American tribal governments and tribal organizations, public housing authorities/Indian housing authorities, as well as specialized categories such as Historically Black Colleges and Universities (HBCUs), Hispanic-serving institutions, Alaska Native and Native Hawaiian-serving institutions, tribally controlled colleges and universities (TCCUs), faith-based or community-based organizations, regional organizations, U.S. territories or possessions, eligible federal agencies, and foreign (non-U.S.) entities.
Overall, the program is designed to accelerate early-stage, human laboratory research that links drug-related behavioral responses with genetics, with the longer-term payoff of improving the field’s ability to explain addiction-related differences across individuals and to develop more targeted prevention and treatment strategies based on biologically meaningful variation.
Frequently Asked Questions (FAQs)
What is the Behavioral Pharmacology and Genetics Translating and Targeting Individual Differences (R03) opportunity?
It is a National Institutes of Health (NIH) funding opportunity (RFA-DA-09-016) that supports research on why individuals differ in their responses to drugs of abuse and how those differences may influence risk for drug misuse and addiction. The program emphasizes linking controlled, measurable drug-related behaviors with genetic factors that may help explain those behaviors.
What is the main scientific goal of this funding opportunity?
The goal is to identify genetic variations that help explain differences in drug effects and related behaviors, clarify underlying biochemical and biological mechanisms, and ultimately point toward more personalized, genetically informed approaches to addiction prevention and treatment.
What kinds of studies does this R03 specifically aim to support?
The opportunity is aimed at controlled, human laboratory-based experimental studies that measure quantifiable behavioral outcomes related to drug effects and pair those measures with genetic analyses. It is designed to support compact, self-contained projects that can be completed with limited resources.
What are examples of behavioral outcomes that may be measured in supported studies?
Examples highlighted include acute drug response, reinforcement, craving, subjective effects, cognitive or psychomotor changes, stress reactivity, and other quantifiable behavioral outcomes measured under controlled conditions.
What is meant by "individual differences" in response to drugs of abuse?
In this context, individual differences refer to measurable ways people vary in how they experience and respond to drugs of abuse (such as subjective effects or craving). The opportunity frames this variability as potentially reflecting underlying genetic differences associated with vulnerability or resilience to addiction.
What role do genetic analyses play in this opportunity?
Genetic analyses are expected to be paired with controlled behavioral measurements to help explain why observed drug-related behaviors differ across individuals and to identify genetic factors that may contribute to those differences.
What are "drug abuse phenotypes" in the context of this announcement?
Drug abuse phenotypes are observable characteristics related to drug use and misuse that can be measured and studied, particularly within controlled human laboratory settings as described in the opportunity.
What are "endophenotypes" and how do they relate to the research focus?
Endophenotypes are more specific, measurable traits that sit between genes and broader clinical outcomes. The opportunity indicates that projects may examine endophenotypes as a way to more precisely connect genetic factors with drug-related behaviors and addiction risk.
What are the main research target areas highlighted in the announcement?
The announcement highlights three main target areas: (a) genetic contributions to individual differences in response to drugs of abuse, (b) genetic influences on differences in the consequences of repeated drug use or abuse over time, and (c) pharmacogenetic differences in response to medications being tested or already used to treat addiction.
Does the opportunity include research on treatment response?
Yes. One of the stated target areas is pharmacogenetic differences in how individuals respond to medications that are being tested or are already used to treat addiction.
Why does the program emphasize controlled human laboratory methods?
Because the opportunity is focused on connecting measurable behavioral responses to genetic factors, it prioritizes controlled experimental approaches where drug-related behaviors can be quantified under defined conditions.
What grant mechanism is used for this opportunity?
This opportunity uses the NIH R03 mechanism, which is intended for small, short-term research projects that can be completed with limited resources.
What types of projects are typically appropriate for an NIH R03 in this program?
The R03 mechanism is described here as supporting pilot studies, feasibility studies, and other compact, self-contained projects that generate early data or test a new approach.
Is this opportunity intended to support new collaborations?
Yes. A major emphasis is placed on encouraging new collaborations, particularly partnerships that combine expertise in genetics with expertise in drug abuse research and human behavioral pharmacology.
How is this R03 positioned in relation to later, larger NIH applications?
The program is positioned as a stepping stone. Teams may use R03 support to develop preliminary findings and methods that could make them more competitive for a larger, longer-term R01 application later.
What is the CFDA number associated with this grant opportunity?
The relevant CFDA number listed is 93.279, which corresponds to Drug Abuse and Addiction Research Programs.
What type of funding opportunity is this categorized as?
It is categorized as a discretionary grant in the health and education-related research area.
Is cost sharing or matching required?
No. The opportunity states that it does not require cost sharing or matching.
What was the estimated total funding amount for the referenced competition cycle?
The estimated total funding amount stated for the competition cycle referenced in the notice is $2,000,000.
When was the funding announcement posted?
The announcement was posted on October 1, 2008.
What were the closing date and archive date listed for this opportunity?
The original and current closing date listed is January 27, 2009, and the archive date listed is February 27, 2009.
Who is eligible to apply?
Eligibility is broad and includes many types of U.S. and non-U.S. organizations. Eligible applicants include public and private institutions of higher education; nonprofit organizations (with or without 501(c)(3) status); for-profit organizations (other than small businesses and including small businesses where applicable); and government entities such as state, county, city/township, special district governments, and independent school districts.
Are tribal governments and tribal organizations eligible?
Yes. The eligibility list explicitly includes Native American tribal governments and tribal organizations.
Are public housing authorities eligible to apply?
Yes. Public housing authorities/Indian housing authorities are explicitly included in the eligibility list.
Are minority-serving institutions included in eligibility?
Yes. The eligibility list explicitly includes Historically Black Colleges and Universities (HBCUs), Hispanic-serving institutions, Alaska Native and Native Hawaiian-serving institutions, and tribally controlled colleges and universities (TCCUs).
Are faith-based or community-based organizations eligible?
Yes. Faith-based or community-based organizations are explicitly included in the eligibility list.
Are U.S. territories or possessions eligible?
Yes. U.S. territories or possessions are explicitly included in the eligibility list.
Are foreign (non-U.S.) entities eligible to apply?
Yes. The eligibility list explicitly includes foreign (non-U.S.) entities.
Are eligible federal agencies included as potential applicants?
Yes. Eligible federal agencies are explicitly included in the eligibility list.
What broader impact is this program aiming for?
The program is designed to accelerate early-stage research linking drug-related behavioral responses with genetics, with the longer-term payoff of improving the field's ability to explain addiction-related differences across individuals and to develop more targeted prevention and treatment strategies based on biologically meaningful variation.
Browse more opportunities from the same category: Education Health
Next opportunity: USA Medical Research and Materiel Command Broad Agency Announcement
Previous opportunity: Parliamentary Strengthening Project in Bosnia Herzegovina
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA DA 09 016
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (RFA DA 09 016) also looked into and applied for these:
| Funding Opportunity |
|---|
| Biosignatures of Chronic Drug Exposure (R21) Apply for RFA DA 09 022 Funding Number: RFA DA 09 022 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Drug Abuse Epidemiology and Services Research in Cooperation with the Clinical and Translational Science Awards Consortium (R01) Apply for PAS 09 001 Funding Number: PAS 09 001 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Small Grants Program for Cancer Epidemiology (R03) Apply for PAR 08 237 Funding Number: PAR 08 237 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Unique Interactions Between Tobacco Use and HIV/AIDS (R01) Apply for PA 08 253 Funding Number: PA 08 253 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Unique Interactions Between Tobacco Use and HIV/AIDS (R03) Apply for PA 08 254 Funding Number: PA 08 254 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Health Services Research on the Prevention and Treatment of Drug and Alcohol Abuse (R01) Apply for PA 08 263 Funding Number: PA 08 263 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Small Grants for Behavioral Research in Cancer Control (R03) Apply for PAR 09 003 Funding Number: PAR 09 003 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Understanding the Effects of Emerging Cellular, Molecular, and Genomic Technologies on Cancer Health Care Delivery(R01) Apply for PA 09 004 Funding Number: PA 09 004 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Understanding the Effects of Emerging Cellular, Molecular, and Genomic Technologies on Cancer Health Care Delivery (R21) Apply for PA 09 005 Funding Number: PA 09 005 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Health Services Research on the Prevention and Treatment of Drug and Alcohol Abuse (R21) Apply for PA 08 264 Funding Number: PA 08 264 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Health Services Research on the Prevention and Treatment of Drug and Alcohol Abuse (R03) Apply for PA 08 265 Funding Number: PA 08 265 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Exploratory Studies in Cancer Detection, Diagnosis, and Prognosis (R21) Apply for PA 08 267 Funding Number: PA 08 267 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Interactions between Physical Activity and Drug Abuse (R01) Apply for RFA DA 09 013 Funding Number: RFA DA 09 013 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Interactions between Physical Activity and Drug Abuse (R03) Apply for RFA DA 09 014 Funding Number: RFA DA 09 014 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Basic and Preclinical Research on Complementary and Alternative Medicine (CAM) (R01) Apply for PA 09 010 Funding Number: PA 09 010 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| The Mouse Gene Development Initiative (R01) Apply for RFA DA 09 015 Funding Number: RFA DA 09 015 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Medical Management of Older Patients with HIV/AIDS (R01) Apply for PA 09 017 Funding Number: PA 09 017 Agency: National Institutes of Health Category: Education Health Funding Amount: $500,000 |
| International Research Collaboration on Drug Abuse and Addiction Research (R01) Apply for PA 09 020 Funding Number: PA 09 020 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| International Research Collaboration on Drug Abuse and Addiction Research (R21) Apply for PA 09 021 Funding Number: PA 09 021 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| International Research Collaboration on Drug Abuse and Addiction Research (R03) Apply for PA 09 022 Funding Number: PA 09 022 Agency: National Institutes of Health Category: Education Health Funding Amount: $50,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA DA 09 016", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.